StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
23
Publishing Date
2023 - 08 - 16
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 09
1
2023 - 06 - 01
1
2023 - 01 - 30
1
2023 - 01 - 25
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2022 - 11 - 21
1
2022 - 09 - 02
1
2022 - 08 - 19
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 29
1
2022 - 07 - 20
1
2022 - 06 - 15
1
2022 - 06 - 14
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 01 - 07
1
2021 - 08 - 05
1
2021 - 07 - 22
1
Sector
Health technology
23
Manufacturing
5
N/a
1
Professional, scientific, and technical services
1
Tags
Approval
1
Business
2
Cancer
3
Companies
1
Covid
1
Depression
1
Disease
2
Drug
2
Expected
2
Gastrointestinal
1
Global
10
Growth
3
Infections
1
Injection
1
Life
1
Market
17
N/a
23
Narcolepsy
1
Opioid
1
Pharmaceuticals
1
Report
10
Research
4
Response
1
Study
1
System
1
Therapeutics
6
Therapy
1
Treat
1
Treatment
4
Ulcerative colitis
2
Entities
Abbott laboratories
32
Abbvie inc.
37
Adc therapeutics sa
5
Aerie pharmaceuticals, inc.
5
Agios pharmaceuticals, inc.
10
Alkermes plc
4
Alnylam pharmaceuticals, inc.
14
Amgen inc.
34
Arvinas, inc.
24
Astellas pharma inc
26
Astrazeneca plc
45
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
5
Baxter international inc.
6
Beam therapeutics inc.
6
Becton, dickinson and company
6
Beigene, ltd.
10
Biocryst pharmaceuticals, inc.
14
Biohaven pharmaceutical holding company ltd.
15
Biomarin pharmaceutical inc.
4
Biontech se
95
Blueprint medicines corporation
10
Bristol-myers squibb company
61
Clovis oncology, inc.
11
Eli lilly and company
80
Endo international plc
7
Epizyme, inc.
11
Exelixis, inc.
13
Genmab a/s
4
Gilead sciences, inc.
27
Glaxosmithkline plc
64
Global blood therapeutics, inc.
6
Ideaya biosciences, inc.
4
Illumina, inc.
12
Incyte corporation
14
Ionis pharmaceuticals, inc.
5
Johnson & johnson
76
Karyopharm therapeutics inc.
10
Moderna, inc.
7
Morgan stanley
4
Myovant sciences ltd.
14
Neurocrine biosciences, inc.
4
Novartis ag
88
Novo nordisk a/s
11
Omeros corporation
13
Opko health, inc.
6
Orange
29
Otonomy, inc.
13
Pfizer, inc.
692
Regeneron pharmaceuticals, inc.
22
Rigel pharmaceuticals, inc.
11
Sanofi
153
Seagen inc.
7
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
29
Verastem, inc.
10
Viatris inc.
8
Voyager therapeutics, inc.
6
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
ABBV
31
ABT
10
ADMA
4
ALPMF
12
ALPMY
12
AMGN
23
ARCT
26
ARWR
12
AZN
29
AZNCF
27
BAX
5
BHC
7
BIIB
6
BMY
43
CDXS
3
CMXHF
4
CNTG
5
CSLLY
4
CTLT
3
EXEL
27
FNCTF
4
GBT
3
GILD
15
GLAXF
29
GMAB
3
GRFS
6
GSK
34
HCM
7
INCY
16
JAZZ
6
JNJ
82
KPTI
7
LLY
42
LOGC
4
MGNX
4
MNK
4
MNKKQ
4
MNKPF
4
MOR
13
MPSYF
11
MRNA
5
NBIX
9
NVAX
4
NVO
15
NVS
58
NVSEF
51
OVID
6
PFE
23
REGN
6
SNY
60
SNYNF
51
TAK
421
TEVA
5
TEVJF
20
TMO
7
UCBJF
8
UCBJY
8
VRTX
4
VTRS
7
XNCR
12
Exchanges
Nasdaq
22
Nyse
23
Crawled Date
2023 - 08 - 16
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 09
1
2023 - 06 - 01
1
2023 - 01 - 30
1
2023 - 01 - 25
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2022 - 11 - 21
1
2022 - 09 - 02
1
2022 - 08 - 19
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 29
1
2022 - 07 - 20
1
2022 - 06 - 15
1
2022 - 06 - 14
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 01 - 07
1
2021 - 08 - 05
1
2021 - 07 - 22
1
Crawled Time
01:00
2
11:00
1
12:00
4
13:00
1
13:20
1
14:00
2
15:15
1
15:20
2
17:00
1
18:00
2
19:00
2
21:00
1
22:00
2
23:00
1
Source
www.prnewswire.com
23
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Takeda pharmaceutical company limited
symbols :
PFE
save search
Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-13.43%
|
O:
-0.26%
H:
0.26%
C:
-0.46%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-28.17%
|
O:
-0.71%
H:
1.45%
C:
0.97%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
34.55%
|
O:
-0.3%
H:
1.35%
C:
0.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.49%
|
O:
-1.33%
H:
0.0%
C:
0.0%
report
approval
research
global
growth
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.61%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-31.09%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.46%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-11.42%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.18%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
65.82%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.45%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.83%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence
Published:
2023-06-09
(Crawled : 22:00)
- prnewswire.com
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
IRWD
|
$7.94
4.47%
4.28%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
opioid
global
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-8.39%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.24%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.14%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-21.17%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.15%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.32%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-9.41%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.28%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.23%
|
O:
1.09%
H:
2.18%
C:
-1.43%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.97%
|
O:
-0.19%
H:
0.13%
C:
-0.69%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.95%
|
O:
0.0%
H:
0.79%
C:
-0.55%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-13.84%
|
O:
-0.18%
H:
0.36%
C:
-3.53%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.23%
|
O:
-0.13%
H:
0.78%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.17%
|
O:
1.3%
H:
0.06%
C:
-0.81%
global
report
gastrointestinal
therapeutics
market
Insights on the Insomnia Global Market to 2028 - Featuring Eisai, Takeda Pharmaceutical, Vanda Pharmaceuticals and Cadila Healthcare Among Others
Published:
2023-01-25
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-5.73%
|
O:
-0.92%
H:
1.41%
C:
1.41%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.47%
|
O:
0.25%
H:
0.53%
C:
0.43%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-43.14%
|
O:
0.72%
H:
0.18%
C:
0.09%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.16%
|
O:
0.39%
H:
0.0%
C:
0.0%
pharmaceuticals
global
market
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published:
2023-01-18
(Crawled : 12:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-94.91%
|
O:
-0.13%
H:
3.25%
C:
-3.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.58%
|
O:
0.62%
H:
0.12%
C:
-0.68%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-44.84%
|
O:
-1.16%
H:
0.67%
C:
-1.2%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-15.9%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.86%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
-27.97%
|
O:
0.07%
H:
2.69%
C:
0.32%
market
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published:
2023-01-13
(Crawled : 13:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.69%
|
O:
-0.13%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-2.42%
|
O:
2.77%
H:
0.63%
C:
0.63%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.45%
|
O:
0.13%
H:
2.35%
C:
2.16%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.72%
|
O:
-0.44%
H:
1.39%
C:
0.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.78%
|
O:
0.15%
H:
0.65%
C:
0.4%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.7%
|
O:
-0.47%
H:
0.47%
C:
0.14%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.06%
|
O:
0.13%
H:
1.04%
C:
0.57%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.9%
|
O:
1.89%
H:
0.0%
C:
0.0%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
-19.79%
|
O:
-1.16%
H:
2.27%
C:
0.42%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-2.59%
|
O:
1.27%
H:
0.78%
C:
0.15%
treatment
disease
expected
Insights on the Narcolepsy Therapeutics Global Market to 2028 - Featuring Jazz Pharmaceuticals, Pfizer, Bioprojet and Takeda Pharmaceutical Among Others
Published:
2022-11-21
(Crawled : 21:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.54%
|
O:
0.71%
H:
0.85%
C:
0.42%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.24%
|
O:
0.33%
H:
1.88%
C:
1.53%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-28.05%
|
O:
0.28%
H:
2.75%
C:
2.63%
global
narcolepsy
therapeutics
market
8 MM Ulcerative Colitis Market Forecasts, Epidemiology & Pipeline Analysis 2022-2027: Novel Emerging Drugs will Shift the Inflammatory Bowel Disease (IBD) Treatment Paradigm
Published:
2022-09-02
(Crawled : 18:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-47.61%
|
O:
1.43%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-4.29%
|
O:
-0.15%
H:
0.29%
C:
-1.02%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-45.49%
|
O:
0.24%
H:
0.13%
C:
-2.23%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.87%
|
O:
0.21%
H:
0.86%
C:
-0.99%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.34%
|
O:
2.55%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
142.87%
|
O:
0.32%
H:
0.04%
C:
-2.83%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
32.63%
|
O:
1.06%
H:
1.35%
C:
-3.15%
treatment
disease
market
ulcerative colitis
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.94%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.26%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.67%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.86%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
44.23%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.64%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.65%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
LAMEA Peptide Therapeutics Market Report 2022: Annual Growth of 12.5% Expected Through 2028
Published:
2022-08-05
(Crawled : 15:20)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
-5.42%
|
O:
-4.5%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-2.01%
|
O:
-6.04%
H:
2.59%
C:
2.59%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.85%
|
O:
3.16%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.47%
|
O:
0.59%
H:
0.0%
C:
-4.45%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
-5.41%
|
O:
-3.78%
H:
0.57%
C:
0.36%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.6%
|
O:
-0.65%
H:
0.29%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.02%
|
O:
-0.44%
H:
0.66%
C:
-0.75%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.21%
|
O:
-0.16%
H:
0.71%
C:
0.56%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.46%
|
O:
-1.26%
H:
1.36%
C:
1.2%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
145.52%
|
O:
-1.08%
H:
0.94%
C:
-0.38%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.82%
|
O:
-0.32%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.98%
|
O:
-0.63%
H:
0.63%
C:
0.24%
report
expected
therapeutics
growth
market
Global Cancer Therapies Market Report 2022: Market to Reach $209.2 Billion by 2026 - Industry Focuses on New Approaches to Treat Cancer
Published:
2022-08-03
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.46%
|
O:
-1.22%
H:
1.8%
C:
1.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.84%
|
O:
2.52%
H:
0.0%
C:
-0.19%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
28.56%
|
O:
-2.88%
H:
0.0%
C:
-0.21%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.33%
|
O:
-0.29%
H:
0.72%
C:
0.58%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.02%
|
O:
0.08%
H:
0.29%
C:
-0.08%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.69%
|
O:
0.2%
H:
0.44%
C:
0.24%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.0%
|
O:
1.4%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.99%
|
O:
0.27%
H:
0.1%
C:
-0.81%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
139.23%
|
O:
-1.16%
H:
0.02%
C:
-1.42%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.83%
|
O:
-0.27%
H:
0.22%
C:
-0.92%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.51%
|
O:
1.13%
H:
0.35%
C:
0.35%
global
report
cancer
market
Statistics on Global Retinal Disorder Treatment Market Size & Share to Surpass USD 15675.74 Million by 2028, Exhibit a CAGR of 7.30% | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research
Published:
2022-07-29
(Crawled : 15:20)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-11.21%
|
O:
-1.22%
H:
0.41%
C:
-0.14%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-49.88%
|
O:
-0.32%
H:
0.3%
C:
-0.1%
treatment
research
global
report
market
IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Players Observe High Demand for TNF Inhibitors, Notes TMR Report
Published:
2022-07-20
(Crawled : 12:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
31.04%
|
O:
-4.54%
H:
3.88%
C:
3.88%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.24%
|
O:
-0.48%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-50.52%
|
O:
0.04%
H:
0.14%
C:
-1.11%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
8.23%
|
O:
-0.81%
H:
0.05%
C:
-1.27%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.69%
|
O:
-2.23%
H:
0.0%
C:
0.0%
treatment
report
market
ulcerative colitis
Antihypertensive Drugs Market is Estimated to Rise at a CAGR of 3% during the Forecast Period, observes TMR Study
Published:
2022-06-15
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.43%
|
O:
0.08%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-0.94%
|
O:
-1.02%
H:
1.6%
C:
1.14%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.68%
|
O:
0.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.65%
|
O:
-0.89%
H:
0.0%
C:
0.0%
market
drug
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published:
2022-06-14
(Crawled : 11:00)
- prnewswire.com
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
55.06%
|
O:
-0.22%
H:
0.0%
C:
-1.02%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-0.98%
|
O:
-0.04%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.87%
|
O:
-2.24%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.89%
|
O:
0.43%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
158.36%
|
O:
-0.49%
H:
0.98%
C:
0.56%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.58%
|
O:
-0.4%
H:
0.33%
C:
-0.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.22%
|
O:
-1.04%
H:
0.87%
C:
-1.31%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
11.35%
|
O:
-0.41%
H:
0.73%
C:
-0.54%
research
system
companies
market
Sports Medicine Devices Market to Grow Due to Rise in Sports Injuries Globally, States TMR Study
Published:
2022-05-09
(Crawled : 12:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.87%
|
O:
-0.69%
H:
0.28%
C:
-1.1%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.21%
|
O:
0.47%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
8.25%
|
O:
-1.83%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
42.96%
|
O:
-2.81%
H:
0.62%
C:
-2.11%
market
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published:
2022-04-26
(Crawled : 13:20)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.47%
|
O:
-1.81%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.62%
|
O:
3.09%
H:
0.0%
C:
-2.9%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
9.65%
|
O:
-0.33%
H:
0.0%
C:
-1.56%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-1.79%
|
O:
-1.19%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.75%
|
O:
-0.48%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.84%
|
O:
3.08%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-20.62%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
163.24%
|
O:
0.34%
H:
1.41%
C:
-1.17%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-36.49%
|
O:
-0.09%
H:
1.26%
C:
-0.51%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
45.38%
|
O:
-0.22%
H:
0.43%
C:
-1.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.78%
|
O:
-0.11%
H:
0.0%
C:
0.0%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-60.38%
|
O:
-0.38%
H:
4.92%
C:
-4.55%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
30.54%
|
O:
-0.72%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
6.78%
|
O:
-0.13%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.49%
|
O:
-0.03%
H:
0.53%
C:
-1.33%
research
report
therapeutics
market
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.